iohexol has been researched along with globotriaosyl lysosphingolipid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
An Haack, K; Bénichou, B; Bichet, DG; Clarke, LA; Dostalova, G; Fainboim, A; Fellgiebel, A; Forcelini, C; Hopkin, RJ; Mauer, M; Najafian, B; Ramaswami, U; Scott, CR; Shankar, SP; Thurberg, BL; Tylki-Szymańska, A; Tøndel, C; Wijburg, FA | 1 |
1 trial(s) available for iohexol and globotriaosyl lysosphingolipid
Article | Year |
---|---|
Characterization of early disease status in treatment-naive male paediatric patients with Fabry disease enrolled in a randomized clinical trial.
Topics: Adolescent; Biopsy; Brain; Child; Child, Preschool; Demography; Endothelium, Vascular; Fabry Disease; Genotype; Glomerular Filtration Rate; Glycolipids; Humans; Iohexol; Kidney; Male; Mutation; Quality of Life; Skin; Sphingolipids; Trihexosylceramides | 2015 |